The asthma spacers market at a compound annual growth rate (CAGR) of 3.8% during the forecast period from 2023 to 2030. As per the latest research citings of World Health Organization (WHO), approximately 235 million people worldwide are suffering with asthma and by 2029 an additional increase of 100 million is expected. Asthma spacers are beneficial in mitigating dosing discrepancies associated with inhalers and nebulizers.

"Technological advancement and excellent control and coordination obtained while using metered dose inhalers increase the popularity for aerochambers"

Aerochamber is reigning the product segment for asthma spacers market. Latest technological advancement and excellent control and coordination achieved by patient while using metered dose inhalers drive the aerochamber market growth. It has greater adoption rate as it is available in different mask size to fit patients belonging to different age group. Inspirease have gained acknowledgement in the recent years as it is beneficial in increasing the distance between MDI and mouth, thereby lowering the inhalation of propellants in the oropharyngeal region.

"Establishment of premium medicine and significant rise in the launch of professionalized pharmacy chains will provide thrust to retail pharmacy market growth"

Retail pharmacy is dominating the distribution channel segment for asthma spacers market. Establishment of premium medicine and significant rise in the number of pharmacy chains worldwide will provide positive impetus to the retail pharmacy market growth. Increasing demand for metered dose inhalers has led to rise in the over the counter (OTC) sales for asthma spacers in retail pharmacy. E-commerce will capture the market during the forecast period owing to availability of low priced asthma spacers in comparison to retail stores due to low overhead cost. Domestic and international vendors exhibit their product online which provides more options to consumers. Increasing adoption of digital products by consumers facilitates the e-commerce market growth. 

"Rising prevalence of asthma and domicile of key players drive the asthma spacers market growth"

In the present scenario with 34% market share North America is the largest regional segment for asthma spacers market. According to Center for Disease Control and Prevention (CDC) statistics in 2021, the percentage of children under 18 years of age suffering with asthma was 8.4%. Rising prevalence of asthma and domicile of key players such as Allergan, Inc., CONMED Corporation, Trudell Medical International etc. drive the asthma spacers market growth in North America region. Europe is in the second position with 26% market share primarily due to supportive regulatory environment provided by European Medical Agency (EMA) for manufacturing and sale of asthma spacers. Asia Pacific represents 16% market growth and will garner stable growth in the near future due to rising prevalence of respiratory disorders and well established e-commerce sector.

Medical device manufacturers producing asthma spacers are AstraZeneca, Plc., Allergan, Inc., CONMED Corporation, Clement Clarke International Limited, GlaxoSmithkline, Plc., Koninklijke Philips N.V., Medical Developments International, Merck & Co., Inc., PARI Respiratory Equipment, Inc. and Trudell Medical International.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Asthma Spacers market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Asthma Spacers market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Asthma Spacers market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Asthma Spacers market?
• Which is the largest regional market for Asthma Spacers market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Asthma Spacers market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Asthma Spacers market worldwide?